Hoshi K, Senda N, Fujino S
Department of Pharmacology, Hokkaido Institute of Pharmaceutical Sciences, Otaru, Japan.
Res Commun Chem Pathol Pharmacol. 1988 Mar;59(3):291-304.
Repeated coadministration of amitriptyline (AMT) and perphenazine (PPZ) decreased the AMT-induced increase of hepatic microsomal aminopyrine N-demethylase, aniline hydroxylase, NADPH-cytochrome c reductase and UDP-glucuronyltransferase (UDP-GT) activities in rats. This may be explained by a fact that inhibition of AMT metabolism in hepatic microsomes by PPZ led to increase the non-conjugated formation of AMT and its metabolites in the liver, brain, urine and feces. On the other hand, a slight decrease of drug metabolizing enzyme activity by diazepam (DZP) but not by nitrazepam (NTZ) was enhanced by combined treatment of AMT, whereas the enhancement of UDP-GT activity by DZP or NTZ was suppressed by coadministration of AMT. At the same time there was no clear increase of non-conjugated formation of AMT metabolites in rat urine and feces during combined treatment.
反复联合给予阿米替林(AMT)和奋乃静(PPZ)可降低AMT诱导的大鼠肝微粒体氨基比林N-脱甲基酶、苯胺羟化酶、NADPH-细胞色素c还原酶和UDP-葡萄糖醛酸转移酶(UDP-GT)活性的增加。这可能是由于PPZ对肝微粒体中AMT代谢的抑制导致肝脏、脑、尿液和粪便中AMT及其代谢产物的非结合形式增加。另一方面,地西泮(DZP)而非硝西泮(NTZ)引起的药物代谢酶活性的轻微降低在AMT联合治疗时增强,而DZP或NTZ引起的UDP-GT活性增强在AMT联合给药时受到抑制。同时,联合治疗期间大鼠尿液和粪便中AMT代谢产物的非结合形式没有明显增加。